Cargando…

Pulmonary Artery Stents-Still "Off Label"

Detalles Bibliográficos
Autor principal:	Kim, Seong-Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Cardiology 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3283761/ https://www.ncbi.nlm.nih.gov/pubmed/22363377 http://dx.doi.org/10.4070/kcj.2012.42.1.8

Ejemplares similares

Pulmonary artery catheter – Dilemma is still on?
por: Sarkar, Manjula, et al.
Publicado: (2021)

To Stent or Not to Stent in Colorectal Cancer: That is Still the Question in Gastroenterology!
por: Pires, Sara, et al.
Publicado: (2016)

Is It Still “Idiopathic”? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension
por: Frech, Tracy M., et al.
Publicado: (2022)

When is off-label off-road?
por: de Vries, E G E, et al.
Publicado: (2019)

Diffuse Long Coronary Artery Disease is Still an Obstacle for Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era?
por: Oh, Pyung Chun, et al.
Publicado: (2019)

Challenges on off label medicine use
por: Carvalho, Marisa Lima
Publicado: (2016)

Stent platforms anno 2015: is there still a place for bare metal stents at the front line?
por: van der Sijde, Jors Nicolaas, et al.
Publicado: (2015)

Off-label use of interwoven carotid stent in common femoral artery occlusion after surgery
por: Ferretto, Luca, et al.
Publicado: (2023)

Drainage of walled-off necrosis: when can I still use plastic stents?
por: Topazian, Mark
Publicado: (2023)

Gabapentin May Be Appropriate for Off-Label Uses
por: Davis, Shawn
Publicado: (2003)

Flow diversion for indirect carotid-cavernous fistula: Still an off-label indication?
por: Brunasso, Lara, et al.
Publicado: (2023)

Five-year clinical outcomes of drug-eluting stents according to on-label and off-label use
por: Park, Kyu-Hwan, et al.
Publicado: (2016)

Off-Pump Coronary Artery Bypass Grafting; is it Still Relevant?
por: Ofoegbu, Chima. K.P., et al.
Publicado: (2022)

Off-label use of drugs: An evil or a necessity?
por: Gota, Vikram, et al.
Publicado: (2015)

Moving Beyond the Endothelium is Still Challenging-Complex Interplay between Endothelin and Reactive Oxygen Species in Pulmonary Arterial Hypertension
por: Chung, Hyemoon, et al.
Publicado: (2019)

Weighing in on the Off-Label Use: Initial Experience of Neuroform EZ Stenting for Intracranial Arterial Stenosis in 45 Patients
por: Du, Zhihua, et al.
Publicado: (2018)

Off-label Medication Use: A Double-edged Sword
por: Agarwal, Vandana
Publicado: (2021)

Use of Drugs for Off-Label Indications: Living in the Same World
por: Barbuto, John P.
Publicado: (2003)

Tropical Infectious Diseases: Still Here, Still Raging, Still Killing
por: Hotez, Peter J.
Publicado: (2021)

Endovascular Therapy of Iliac Artery Disease: Stent Matters
por: Kim, Su Hong
Publicado: (2021)

A tale of two drugs: Off and on-label
por: Narayanan, Raja, et al.
Publicado: (2017)

Are anticoagulants still indicated in pulmonary arterial hypertension?
por: Olschewski, Horst, et al.
Publicado: (2018)

An off-label use of flow-diverter stent as a successful treatment of a postoperative middle cerebral artery pseudoaneurysm
por: Theocharidou, Anastasia, et al.
Publicado: (2023)

Intramural Coronary Artery Course in Jatene Operation for Transposition of Great Arteries: Still a Challenge
por: Jatene, Marcelo Biscegli, et al.
Publicado: (2016)

Frustration Still Exists
por: Kim, Hyun Shig
Publicado: (2014)

Off-label indications for bioresorbable scaffolds: “Beethoven can, but you cannot”
por: Gutiérrez-Chico, Juan Luis, et al.
Publicado: (2016)

Self-Expandable Metal Stent as a Bridge to Surgery for Obstructing Colonic Cancer: Still a Hot Topic for Debate
por: Coelho, Rosa, et al.
Publicado: (2016)

The evolution of transcarotid artery stenting with flow reversal
por: Malgor, Rafael Demarchi, et al.
Publicado: (2019)

To β-Block or Not to β-Block: That Is Still the Question in Chronic Obstructive Pulmonary Disease
por: Hancox, Robert J.
Publicado: (2022)

The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting?
por: Wessels, Jeroen N., et al.
Publicado: (2020)

From Arterial Stiffness to Heart Failure: Still a Long Way to Go
por: Canepa, Marco, et al.
Publicado: (2015)

Proximal Protected Carotid Artery Stenting and Neurologic Intolerance: Can We Predict before Stenting?
por: Rha, Seung-Woon
Publicado: (2018)

Long-Term Predictors of Clinical Events after Off-Label Use of Drug-Eluting Stent beyond 1 Year
por: Yun, Kyeong Ho, et al.
Publicado: (2013)

Pulmonary artery banding in the current era: Is it still useful?
por: Dehaki, Maziar Gholampour, et al.
Publicado: (2012)

Still the Cinderella
Publicado: (1961)

Still at School
Publicado: (1872)

Pulmonary Artery Banding is Still a Valuable Option
por: Durandy, Yves
Publicado: (2013)

Peeling off musculoskeletal labels: sticks and stones may break my bones, but diagnostic labels can hamstring me forever
por: Friedman, Daniel Jonah, et al.
Publicado: (2021)

Off-label use of medicines: Medical research and medical practice
por: Khamar, Bakulesh
Publicado: (2007)

Off with the label and on the Avastin bandwagon: Why now and how far?
por: Gopal, K. S. Santhan
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_8n6mins595fljfc18m1djcn7c4